His research on Cancer research frequently links to adjacent areas such as Liver cancer. He conducts interdisciplinary study in the fields of Liver cancer and Liver disease through his works. His work often combines Liver disease and Hepatocellular carcinoma studies. His Hepatocellular carcinoma study frequently draws parallels with other fields, such as Cancer research. Nabeel Bardeesy connects Mutation with Enzyme in his study. Nabeel Bardeesy undertakes multidisciplinary investigations into Enzyme and Isocitrate dehydrogenase in his work. Nabeel Bardeesy merges many fields, such as Isocitrate dehydrogenase and IDH1, in his writings. Nabeel Bardeesy regularly ties together related areas like Gene in his IDH1 studies. Nabeel Bardeesy merges Gene with Genetics in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Reuben J. Shaw;Reuben J. Shaw;Katja A. Lamia;Debbie Vasquez;Seung Hoi Koo;Seung Hoi Koo.
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
Reuben J. Shaw;Monica Kosmatka;Nabeel Bardeesy;Rebecca L. Hurley.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway
Jaekyoung Son;Costas A. Lyssiotis;Costas A. Lyssiotis;Haoqiang Ying;Xiaoxu Wang.
Pancreatic cancer biology and genetics
Nabeel Bardeesy;Ronald A. DePinho.
Nature Reviews Cancer (2002)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang;Xiaoxu Wang;Gianmarco Contino;Marc Liesa.
Genes & Development (2011)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying;Prasenjit Dey;Wantong Yao;Alec C. Kimmelman.
Genes & Development (2006)
The LKB1 tumor suppressor negatively regulates mTOR signaling
Reuben J Shaw;Nabeel Bardeesy;Brendan D Manning;Lyle Lopez.
Cancer Cell (2004)
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
Norman E. Sharpless;Nabeel Bardeesy;Kee Ho Lee;Daniel Carrasco.
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
Andrew J. Aguirre;Nabeel Bardeesy;Manisha Sinha;Lyle Lopez.
Genes & Development (2003)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Benjamin J. Raphael;Ralph H. Hruban;Andrew J. Aguirre;Richard A. Moffitt.
Cancer Cell (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: